Madrigal Pharmaceuticals (MDGL) announced that Ronald Filippo has been appointed Chief Information Officer. Filippo has more than 25 years of digital experience in the biopharmaceutical industry and was previously Senior Vice President Digital at Moderna (MRNA), where he was responsible for technology leadership and digital transformation across core operations during the commercialization of the company’s COVID-19 vaccine.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDGL:
- Madrigal Pharmaceuticals Appoints Ronald Filippo as Chief Information Officer
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Paulson exits Newmont, boosts Madrigal in Q3
- Madrigal price target raised to $275 from $225 at H.C. Wainwright